TY - JOUR
T1 - Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine
T2 - Current situation and future development
AU - BIAN, Zhaoxiang
AU - Liu, Baoyan
AU - Moher, David
AU - Wu, Taixiang
AU - Li, Youping
AU - Shang, Hongcai
AU - Cheng, Chungwah
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2011/6
Y1 - 2011/6
N2 - The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.
AB - The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.
KW - CONSORT for TCM
KW - Future development
KW - Reporting standards
UR - http://www.scopus.com/inward/record.url?scp=80355129340&partnerID=8YFLogxK
U2 - 10.1007/s11684-011-0132-z
DO - 10.1007/s11684-011-0132-z
M3 - Review article
C2 - 21695622
AN - SCOPUS:80355129340
SN - 2095-0217
VL - 5
SP - 171
EP - 177
JO - Frontiers of Medicine
JF - Frontiers of Medicine
IS - 2
ER -